Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Cognitive Diagnostics Market Snapshot

The global cognitive diagnostics market enjoys a valuation of US$ 102.9 Billion in 2022, and it is further projected to expand at a CAGR of 8.0% over the forecasted years. According to a recent study by Future Market Insights, the laboratory testing diagnosis segment is leading the market with a share of about 24.8% in the year 2022, within the global market.

Market Outlook

Data Points Market Insights
Market Value 2022 US$ 102.9 Billion
Market Value 2033 US$ 238.3 Billion
CAGR 2023 to 2033 8.0%
Market Share of Top 5 Countries 54.7%
Key Market Players Cognetivity Neurosciences, Cognivue, Inc., Cogstate Ltd., Cambridge Cognition Ltd., Diadem srl, and CN Diagnostics.

The market of cognitive diagnostics refers to the field of medical technology that involves the assessment and diagnosis of cognitive disorders, such as Alzheimer's disease, dementia, and other neurological conditions. This market is driven by the growing demand for accurate and reliable diagnostic tools, as well as the increasing prevalence of cognitive disorders globally.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Cognitive Diagnostics Market from 2012 to 2022 Vs Market Outlook for 2023 to 2033.

The global sales of the market are anticipated to rise at a CAGR of 8.0% between 2023 and 2033, owing to the rising prevalence of cognitive disorders, technological advancements, personalized medicine, and point-of-care testing.

The global market holds around 4.2% share of the overall global neurology services market with a value of around US$ 2,446.2 Billion, in 2022.

Brain disorders or cognitive disorders have different aetiology like closed-head injuries, exposure to neurotoxins (toxic substances to nerve tissues), genetics, infections, strokes, and brain tumours. The cognitive disorder type that someone develops is determined by the part of the brain that is affected. For example, an occurrence of a tumour in the brain's speech centres will cause communication problems. Another example is an infection in the brain's motor centres will result in movement issues.

The growing geriatric population further fuels the growth of various disorders and diseases, which drives market expansion. Technology is developing quickly, and machine learning and artificial intelligence (AI) are propelling innovation in the cognitive diagnostics industry. New diagnostic tools and technologies are being developed that can detect cognitive disorders at earlier stages with greater accuracy. For example, a digital pen and fast data analysis system with a new AI tool is developed recently in 2017 at the Massachusetts Institute of Technology (MIT) and examined in the Lahey Hospital for the detection of cognitive impairment.

The market for cognitive diagnostics is increasingly focused on personalized medicine, where diagnostic tests are designed to an individual's particular genetic and cognitive characteristics. This approach is expected to lead to better patient outcomes and more targeted treatments.

In cognitive diagnostics, there is an increasing demand for point-of-care testing, which allows diagnostic tests to be performed in a clinical setting without the need for laboratory analysis. This method enables quicker and more convenient diagnosis, especially in remote or underserved areas.

Owing to the above-mentioned factors, the global market is expected to grow at a prominent pace, and reach a valuation of around US$ 238.3 Billion during the year 2033.

What Are the Key Opportunities for the Manufacturers Operating in the Global Market?

The frequency of cognitive disorders such as Alzheimer's disease, dementia, and other neurological conditions is on the rise globally. This is increasing the demand for accurate and dependable diagnostic tools to identify and diagnose cognitive conditions.

The demand for diagnostic tools and technologies is increasing as people become more conscious of and educated about cognitive disorders. This greater awareness is also resulting in early detection and diagnosis of cognitive disorders, which can result in more effective treatment and management.

Another significant factor propelling the market for cognitive diagnostics is the ageing global populace. The prevalence of cognitive disorders increases with age, increasing the need for diagnostic tools and technologies to evaluate cognitive performance.

  • The World Health Organization (WHO) estimates that 55 Million people have dementia globally in 2023, with 10 Million new cases being reported per year. Dementia occurs from numerous reasons and injuries that affect the brain. Alzheimer’s disease is a prevalent form of dementia; and, can be a factor in 60–70% of cases.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What Are the Factors Restraining Demand within the Global Market?

Certain patient populations cannot have access to many of the expensive diagnostic equipment and technology utilized in cognitive diagnostics. In developing nations or places with few resources, the expensive price of these instruments can prevent their widespread use.

Although there is an increase in public awareness of cognitive problems, healthcare practitioners and the general public are still not adequately informed about the value of early diagnosis and treatment. This can reduce the need for diagnostic tools and technologies, resulting in a moderate rate of uptake and little market expansion. For example, according to National Institute on Aging (NIA) article on cognitive impairment in older patients in 2021, many people who have dementia or are at risk of getting it never get a diagnosis.

According to one study, more than 40% of the patients with cognitive impairment were treated by doctors who were unaware of their condition. The issue of underdiagnosis is considerably more severe among underserved areas and in those with lower levels of education. According to a different study, more than half of dementia patients had not undergone a clinical cognitive evaluation by a doctor. Failure to assess memory or cognitive complaints may impede the treatment of underlying illnesses and coexisting diseases and jeopardize the patient's and others' safety. The cognitive issue will frequently get worse over time.

Data security and privacy are becoming more of a worry as digital health technologies are being used more frequently in cognitive diagnostics. This can prevent the widespread use of these technologies, especially when patient data security is a primary concern.

Country-wise Insights

What Makes the USA a Large Market for Cognitive Diagnostics?

The USA. dominates the North American region with a total market share of around 26.8% in the global market in 2022. The market is expected to expand further as a result of technological advancements and healthcare reforms.

The USA is home to some of the world's leading research institutions, and significant technological advances in cognitive diagnostics, such as new neuroimaging techniques, biomarker development, and genetic testing, have occurred. These advancements are providing more accurate and reliable diagnostic tools for cognitive disorders to healthcare providers in the USA

The healthcare system in the USA is undergoing significant reforms, including a greater emphasis on preventive care and cost containment. In the USA, the use of cognitive diagnostic tools and technologies can help to achieve these goals by allowing for the early detection and treatment of cognitive disorders, which can reduce healthcare costs in the long run.

What Is the Outlook of China in the Global Market?

China has a market share of 9.5% in the global market in 2022, and in the foreseeable period, the market will expand more due to an older population with dementia and collaborations and partnership.

China's population is rapidly ageing, and as a result, the prevalence of cognitive disorders such as Alzheimer's disease is rising. This is increasing the demand for more accurate and dependable diagnostic tools to detect cognitive disorders early on. The significant growth of this market can be attributed to China's large population base over the age of 40.

Collaboration and partnerships between healthcare providers, technology companies, and research institutions are becoming increasingly important in the cognitive diagnostics market. These collaborations can drive innovation, improve access to diagnostic tools and technologies, and accelerate the development of new treatments for cognitive disorders.

  • Cambridge Cognition announced in November 2022 a strategic agreement with Luca Healthcare Ltd. for the expansion of the Chinese market to market the Company's suite of top cognitive assessment products in China for the pharmaceutical and healthcare industries.

What Is the Scenario of Germany within the Global Market Space?

Germany holds a market share of 5.1% in the global market in 2022 and because of increased research activities, government initiatives and funding, and increasing healthcare spending, the German market will grow even more.

Increased research activities in Germany, the German government is increasing funding for Research and Development in cognitive diagnostic tools and technologies, which are spurring innovation and investment in new diagnostic tools and technologies. This is expected to improve diagnostic accuracy as well as patient outcomes.

  • For instance, Researchers from Germany's Ruhr University Bochum have developed a new blood test that can detect Alzheimer's disease indicators much earlier than the onset of symptoms.

Germany has a well-established healthcare system and is increasing healthcare spending, which is increasing demand for more advanced medical technologies, such as cognitive diagnostic tools and technologies. This is expected to drive growth in the German cognitive diagnostics market.

What Makes India a Highly Lucrative Market for Cognitive Diagnostics?

India holds a share of around 6.4% in the global market in 2022. Increasing healthcare spending, rising awareness and education, and government support for research programs are expected to drive the expansion of the global market in India.

India is increasing its healthcare spending, and as a result, there is an increasing demand for more advanced medical technologies, including cognitive diagnostics tools and technologies.

In India, there is a growing awareness and education about cognitive disorders, which is driving demand for more accurate and reliable diagnostic tools. This increased awareness is also leading to earlier detection and diagnosis of cognitive disorders, which can lead to more effective treatment and management.

The Indian government is increasing its funding for research programs in cognitive diagnostic tools and technologies, which is driving innovation and investment in new diagnostic tools and technologies.

  • For instance, the Department of Science and Technology in India started the "Cognitive Science Research Initiatives" (CSRI) initiative in 2008 with the specific goal of studying the human mind and brain.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which Cognitive Diagnostic Is Driving the Market Growth?

Laboratory testing held a market share of about 24.8% in the global market in 2022. Laboratory testing is an important part of the cognitive diagnostics sector because it provides valuable insight into the underlying neurological conditions that can cause cognitive impairment. These tests can detect even subtle changes in cognitive function, allowing for earlier and more accurate diagnoses of cognitive disorders. Technological advancements in laboratory testing, such as neuroimaging, genetic testing, and biomarker analysis, are propelling innovation in the cognitive diagnostics market.

Real-time monitoring of custom testing based on customer needs is made possible by laboratory testing. The validation process is also quickened through laboratory testing.

Which Indication is Large of Concern within the Global Market?

Alzheimer’s disease held a market share at about 24.0% in the global market in 2022 due to the prevalence of Alzheimer’s disease and dementia is rising with the ageing population globally. China, India, South Asia, and Western Pacific neighbours are experiencing the fastest growth in the elderly population.

  • According to the Alzheimer's Disease International organization, a new case of Alzheimer's disease is diagnosed every three seconds.

Overall, drivers such as ageing populations, advances in neuroimaging technologies, biomarker development, increased awareness and education, government initiatives and funding, and improved diagnostic accuracy and patient outcomes are expected to fuel growth and innovation in the cognitive diagnostics sector for Alzheimer's disease indications.

Which End User Benefits from the Sales within the Market?

Hospitals hold a market share of 29.2% in the global market in 2022. The use of cognitive diagnostics tools and technologies in hospitals can lead to improved patient outcomes by enabling early detection, accurate diagnosis, and timely treatment of cognitive disorders. This can help to improve quality of life for patients and reduce the burden on healthcare systems.

Regulatory bodies around the world are increasingly supporting the use of cognitive diagnostics tools and technologies in hospitals. This is driving the development and adoption of new diagnostic tools and technologies, and helping to improve patient outcomes.

Overall, hospital segment will continue to be driven by factors like improved patient outcomes, regulatory support, and long-term cost effectiveness.

Competitive Landscape

The key players are focusing on collaborative agreements with other market players and research organizations to improve market position.

The companies are focusing on accelerating the pace of innovation, prioritizing key platforms and geographies, and restructuring operations, while expanding their business through agreements and partnerships around the world.

A few examples of strategies acquired by the key players

  • In July 2022, Cognivue company launched a ten-minute self-administered computerized assessment based on the FDA-cleared and patented cognitive assessment systems for the diagnosis of cognitive function.
  • In May 2022, Cogstate and Clario expanded their collaboration to provide cutting-edge clinical trial data collection and data quality programs.
  • In May 2022, C?N Diagnostics invented the P-tau Multi-Analyte Assay only for the Research use in the field of Brain Health and Advance Alzheimer’s Disease.

Similarly, recent developments related to companies’ in cognitive diagnostics have been tracked by the team at Future Market Insights. These are available in the full report.

Report Scope as per Cognitive Diagnostics Industry Analysis

Attribute Details
Historical Data Available for 2012 to 2022
Forecast Period 2023 to 2033
Market Analysis US$ Million for Value
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa
Key Countries Covered The USA, Canada, Brazil, Mexico, Argentina, the United kingdom, Germany, Italy, Russia, Spain, France, Benelux, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries and South Africa
Key Market Segments Covered Diagnosis, Indication, End User, and Region
Key Companies Profiled
  • Cognetivity Neurosciences
  • Cognivue, Inc.
  • Cogstate Ltd.
  • Cambridge Cognition Ltd.
  • Diadem srl
  • CN Diagnostics
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing Available upon Request

Key Market Segments Covered in the Cognitive Diagnostics Industry Research

Diagnosis:

  • Brain Imaging Tests
    • Magnetic Resonance Imaging (MRI)
    • Computerized Tomography (CT)
    • Positron Emission Tomography (PET) and PET/CT
  • Laboratory Testing
    • Cerebrospinal fluid (CSF)
    • Blood Tests
  • Mental Status Testing
    • Mini-Mental State Exam (MMSE)
    • Montreal Cognitive Assessment (MoCA)
  • Rapid Home Screening Tests
  • Neuropsychological Testing
  • Electroencephalogram (EEG)
  • Cognitive Function & Behavioral Tests
  • Neuropsychiatric Inventory Questionnaire (NPI-Q)

Indication:

  • Alzheimer’s disease
  • Attention deficit/hyperactivity disorder
  • Dementia
  • Epilepsy-Related Cognitive Dysfunction
  • Mild Cognitive Impairment
  • Parkinson’s Disease-related Cognitive Dysfunction
  • Stroke-related Cognitive Dysfunction
  • Traumatic Brain Injury
  • Others

End User:

  • Hospitals
  • Neurology Clinics
  • Cognitive Behavioral Therapy Centers
  • Rehabilitation Centers
  • Academic and Research Institutes
  • Diagnostic Imaging Centers
  • Home Care Settings

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Growth Potential of this Market?

The growth potential of this market is 8% CAGR through 2033.

What is the market share of the United States?

The United States acquired 26.8% of the global market shares in 2022.

How has the market developed in the Past?

From 2012 to 2022, the global market exhibited a 4.2% CAGR.

Who are the Key Players in the Market?

Cognivue, Inc., Cogstate Ltd., and Diadem srl are the key market players.

What drives sales of this market?

Growing demand for accurate and reliable diagnostic tools drives sales.

Table of Content

1. Executive Summary | Cognitive Diagnostics Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Value Added Insights

    4.1. Disease Epidemiology

        4.1.1. Prevalence Population

        4.1.2. Diagnosed Prevalence Cases

        4.1.3. Gender Specific Cases

        4.1.4. Severity Specific Cases

    4.2. Annual Patient Volume of Diagnosis for Key Countries

    4.3. Regulatory Guidelines

    4.4. Differential Indications for Cognitive Decline

    4.5. Patient Treatment Journey

    4.6. PESTLE Analysis

    4.7. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Life Expectancy Outlook

        5.1.4. Pharmaceutical Spending

        5.1.5. Global Neurology Services Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increase Prevalence of Cognitive Disorders

        5.2.2. Diagnostic Rate (%)

        5.2.3. Treatment Seeking Rate (%)

        5.2.4. Cases treated with Combination Therapy

        5.2.5. Overall Cost of Therapy

        5.2.6. Recent Advancements In Technology

        5.2.7. Regulatory Framework

        5.2.8. Key Strategic Developments By Market Players

        5.2.9. Adverse Effects May Impact the Market Growth

        5.2.10. Growing Investment in Healthcare Sector

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity

6. COVID-19 Crisis – Impact Assessment

    6.1. COVID-19 and Impact Analysis

        6.1.1. Revenue By Diagnosis

        6.1.2. Revenue By Indication

        6.1.3. Revenue By End User

        6.1.4. Revenue By Country

    6.2. 2022 Scenario

7. Global Market Demand (in Value or Size in US$ Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033

    7.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022

    7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Million) Analysis, By Diagnosis, 2012 to 2022

    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Diagnosis, 2023 to 2033

        8.3.1. Brain Imaging Tests

            8.3.1.1. Magnetic Resonance Imaging (MRI)

            8.3.1.2. Computerized Tomography (CT)

            8.3.1.3. Positron Emission Tomography (PET) and PET/CT

        8.3.2. Laboratory Testing

            8.3.2.1. Cerebrospinal fluid (CSF) Tests

            8.3.2.2. Blood Tests

        8.3.3. Mental Status Testing

            8.3.3.1. Mini-Mental State Exam (MMSE)

            8.3.3.2. Montreal Cognitive Assessment (MoCA)

        8.3.4. Rapid Home Screening Tests

        8.3.5. Neuropsychological Testing

        8.3.6. Electroencephalogram (EEG)

        8.3.7. Cognitive Function & Behavioral Tests

        8.3.8. Neuropsychiatric Inventory Questionnaire (NPI-Q)

    8.4. Market Attractiveness Analysis By Diagnosis

9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) Analysis, By Indication, 2012 to 2022

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2023 to 2033

        9.3.1. Alzheimer’s disease

        9.3.2. Attention-deficit/hyperactivity disorder

        9.3.3. Dementia

        9.3.4. Epilepsy-Related Cognitive Dysfunction

        9.3.5. Mild Cognitive Impairment

        9.3.6. Parkinson’s Disease-related Cognitive Dysfunction

        9.3.7. Stroke-related Cognitive Dysfunction

        9.3.8. Traumatic Brain Injury

        9.3.9. Others

    9.4. Market Attractiveness Analysis By Indication

10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis, By End User, 2012 to 2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        10.3.1. Hospitals

        10.3.2. Neurology Clinics

        10.3.3. Cognitive Behavioral Therapy Centers

        10.3.4. Rehabilitation Centers

        10.3.5. Academic and Research Institutes

        10.3.6. Diagnostic Imaging Centers

        10.3.7. Home Care Settings

    10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    12.1. Introduction

    12.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        12.3.1. By Country

            12.3.1.1. USA

            12.3.1.2. Canada

        12.3.2. By Diagnosis

        12.3.3. By Indication

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Diagnosis

        12.4.3. By Indication

        12.4.4. By End User

    12.5. Market Trends

    12.6. Key Market Participants - Intensity Mapping

    12.7. Drivers and Restraints - Impact Analysis

    12.8. Country Level Analysis & Forecast

        12.8.1. USA Market Analysis

            12.8.1.1. Introduction

            12.8.1.2. Market Analysis and Forecast by Market Taxonomy

                12.8.1.2.1. By Diagnosis

                12.8.1.2.2. By Indication

                12.8.1.2.3. By End User

        12.8.2. Canada Market Analysis

            12.8.2.1. Introduction

            12.8.2.2. Market Analysis and Forecast by Market Taxonomy

                12.8.2.2.1. By Diagnosis

                12.8.2.2.2. By Indication

                12.8.2.2.3. By End User

13. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022

    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        13.3.1. By Country

            13.3.1.1. Mexico

            13.3.1.2. Brazil

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Diagnosis

        13.3.3. By Indication

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Diagnosis

        13.4.3. By Indication

        13.4.4. By End User

    13.5. Market Trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

    13.8. Country Level Analysis & Forecast

        13.8.1. Mexico Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast by Market Taxonomy

                13.8.1.2.1. By Diagnosis

                13.8.1.2.2. By Indication

                13.8.1.2.3. By End User

        13.8.2. Brazil Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast by Market Taxonomy

                13.8.2.2.1. By Diagnosis

                13.8.2.2.2. By Indication

                13.8.2.2.3. By End User

        13.8.3. Argentina Market Analysis

            13.8.3.1. Introduction

            13.8.3.2. Market Analysis and Forecast by Market Taxonomy

                13.8.3.2.1. By Diagnosis

                13.8.3.2.2. By Indication

                13.8.3.2.3. By End User

14. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022

    14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. United kingdom

            14.3.1.2. Germany

            14.3.1.3. France

            14.3.1.4. Italy

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Nordics

            14.3.1.9. Rest of Europe

        14.3.2. By Diagnosis

        14.3.3. By Indication

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Diagnosis

        14.4.3. By Indication

        14.4.4. By End User

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. United kingdom Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Diagnosis

                14.8.1.2.2. By Indication

                14.8.1.2.3. By End User

        14.8.2. Germany Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Diagnosis

                14.8.2.2.2. By Indication

                14.8.2.2.3. By End User

        14.8.3. France Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast by Market Taxonomy

                14.8.3.2.1. By Diagnosis

                14.8.3.2.2. By Indication

                14.8.3.2.3. By End User

        14.8.4. Italy Market Analysis

            14.8.4.1. Introduction

            14.8.4.2. Market Analysis and Forecast by Market Taxonomy

                14.8.4.2.1. By Diagnosis

                14.8.4.2.2. By Indication

                14.8.4.2.3. By End User

        14.8.5. Spain Market Analysis

            14.8.5.1. Introduction

            14.8.5.2. Market Analysis and Forecast by Market Taxonomy

                14.8.5.2.1. By Diagnosis

                14.8.5.2.2. By Indication

                14.8.5.2.3. By End User

        14.8.6. BENELUX Market Analysis

            14.8.6.1. Introduction

            14.8.6.2. Market Analysis and Forecast by Market Taxonomy

                14.8.6.2.1. By Diagnosis

                14.8.6.2.2. By Indication

                14.8.6.2.3. By End User

        14.8.7. Russia Market Analysis

            14.8.7.1. Introduction

            14.8.7.2. Market Analysis and Forecast by Market Taxonomy

                14.8.7.2.1. By Diagnosis

                14.8.7.2.2. By Indication

                14.8.7.2.3. By End User

        14.8.8. Nordics Market Analysis

            14.8.8.1. Introduction

            14.8.8.2. Market Analysis and Forecast by Market Taxonomy

                14.8.8.2.1. By Diagnosis

                14.8.8.2.2. By Indication

                14.8.8.2.3. By End User

15. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022

    15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Diagnosis

        15.3.3. By Indication

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Diagnosis

        15.4.3. By Indication

        15.4.4. By End User

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. China Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Diagnosis

                15.8.1.2.2. By Indication

                15.8.1.2.3. By End User

        15.8.2. Japan Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Diagnosis

                15.8.2.2.2. By Indication

                15.8.2.2.3. By End User

        15.8.3. South Korea Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Diagnosis

                15.8.3.2.2. By Indication

                15.8.3.2.3. By End User

16. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022

    16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Malaysia

            16.3.1.3. Thailand

            16.3.1.4. Indonesia

            16.3.1.5. Philippines

            16.3.1.6. Vietnam

            16.3.1.7. Rest of South Asia

        16.3.2. By Diagnosis

        16.3.3. By Indication

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Diagnosis

        16.4.3. By Indication

        16.4.4. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. India Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Diagnosis

                16.8.1.2.2. By Indication

                16.8.1.2.3. By End User

        16.8.2. Malaysia Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Diagnosis

                16.8.2.2.2. By Indication

                16.8.2.2.3. By End User

        16.8.3. Thailand Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Diagnosis

                16.8.3.2.2. By Indication

                16.8.3.2.3. By End User

        16.8.4. Indonesia Market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast by Market Taxonomy

                16.8.4.2.1. By Diagnosis

                16.8.4.2.2. By Indication

                16.8.4.2.3. By End User

        16.8.5. Philippines Market Analysis

            16.8.5.1. Introduction

            16.8.5.2. Market Analysis and Forecast by Market Taxonomy

                16.8.5.2.1. By Diagnosis

                16.8.5.2.2. By Indication

                16.8.5.2.3. By End User

        16.8.6. Vietnam Market Analysis

            16.8.6.1. Introduction

            16.8.6.2. Market Analysis and Forecast by Market Taxonomy

                16.8.6.2.1. By Diagnosis

                16.8.6.2.2. By Indication

                16.8.6.2.3. By End User

17. Oceania Market 2012 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022

    17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Diagnosis

        17.3.3. By Indication

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Diagnosis

        17.4.3. By Indication

        17.4.4. By End User

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. Australia Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Diagnosis

                17.8.1.2.2. By Indication

                17.8.1.2.3. By End User

        17.8.2. New Zealand Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Diagnosis

                17.8.2.2.2. By Indication

                17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2012 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2012 to 2022

    18.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Türkiye

            18.3.1.3. South Africa

            18.3.1.4. Israel

            18.3.1.5. North Africa

            18.3.1.6. Rest of Middle East and Africa

        18.3.2. By Diagnosis

        18.3.3. By Indication

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Diagnosis

        18.4.3. By Indication

        18.4.4. By End User

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. GCC Countries Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Diagnosis

                18.8.1.2.2. By Indication

                18.8.1.2.3. By End User

        18.8.2. Türkiye Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Diagnosis

                18.8.2.2.2. By Indication

                18.8.2.2.3. By End User

        18.8.3. South Africa Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Diagnosis

                18.8.3.2.2. By Indication

                18.8.3.2.3. By End User

        18.8.4. Israel Market Analysis

            18.8.4.1. Introduction

            18.8.4.2. Market Analysis and Forecast by Market Taxonomy

                18.8.4.2.1. By Diagnosis

                18.8.4.2.2. By Indication

                18.8.4.2.3. By End User

        18.8.5. North Africa Market Analysis

            18.8.5.1. Introduction

            18.8.5.2. Market Analysis and Forecast by Market Taxonomy

                18.8.5.2.1. By Diagnosis

                18.8.5.2.2. By Indication

                18.8.5.2.3. By End User

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Key Development Analysis

    19.3. Market Presence Analysis, Key Players – Market Footprint

    19.4. Branding and Promotional Strategies, by Manufacturers

    19.5. Competition Deep Dive

        19.5.1. Cognetivity Neurosciences

            19.5.1.1. Overview

            19.5.1.2. Product Portfolio

            19.5.1.3. Key Financials

            19.5.1.4. SWOT Analysis

            19.5.1.5. Key Developments

            19.5.1.6. Sales Footprint

            19.5.1.7. Strategy Overview

                19.5.1.7.1. Marketing Strategies

                19.5.1.7.2. Product Strategies

                19.5.1.7.3. Channel Strategies

        19.5.2. Cognivue, Inc.

            19.5.2.1. Overview

            19.5.2.2. Product Portfolio

            19.5.2.3. Key Financials

            19.5.2.4. SWOT Analysis

            19.5.2.5. Key Developments

            19.5.2.6. Sales Footprint

            19.5.2.7. Strategy Overview

                19.5.2.7.1. Marketing Strategies

                19.5.2.7.2. Product Strategies

                19.5.2.7.3. Channel Strategies

        19.5.3. Cogstate Ltd.

            19.5.3.1. Overview

            19.5.3.2. Product Portfolio

            19.5.3.3. Key Financials

            19.5.3.4. SWOT Analysis

            19.5.3.5. Key Developments

            19.5.3.6. Sales Footprint

            19.5.3.7. Strategy Overview

                19.5.3.7.1. Marketing Strategies

                19.5.3.7.2. Product Strategies

                19.5.3.7.3. Channel Strategies

        19.5.4. Cambridge Cognition Ltd.

            19.5.4.1. Overview

            19.5.4.2. Product Portfolio

            19.5.4.3. Key Financials

            19.5.4.4. SWOT Analysis

            19.5.4.5. Key Developments

            19.5.4.6. Sales Footprint

            19.5.4.7. Strategy Overview

                19.5.4.7.1. Marketing Strategies

                19.5.4.7.2. Product Strategies

                19.5.4.7.3. Channel Strategies

        19.5.5. Diadem srl

            19.5.5.1. Overview

            19.5.5.2. Product Portfolio

            19.5.5.3. Key Financials

            19.5.5.4. SWOT Analysis

            19.5.5.5. Key Developments

            19.5.5.6. Sales Footprint

            19.5.5.7. Strategy Overview

                19.5.5.7.1. Marketing Strategies

                19.5.5.7.2. Product Strategies

                19.5.5.7.3. Channel Strategies

        19.5.6. C₂N Diagnostics

            19.5.6.1. Overview

            19.5.6.2. Product Portfolio

            19.5.6.3. Key Financials

            19.5.6.4. SWOT Analysis

            19.5.6.5. Key Developments

            19.5.6.6. Sales Footprint

            19.5.6.7. Strategy Overview

                19.5.6.7.1. Marketing Strategies

                19.5.6.7.2. Product Strategies

                19.5.6.7.3. Channel Strategies

20. Assumptions and Acronyms Used

21. Research Methodology

List of Tables

Table 01: Global Market Size (US$ Million) Analysis 2012 to 2022, By Diagnosis

Table 02: Global Market Size (US$ Million) Forecast 2023 to 2033, By Diagnosis

Table 03: Global Market Size (US$ Million) Analysis 2012 to 2022, By Indication

Table 04: Global Market Size (US$ Million) Forecast 2023 to 2033, By Indication

Table 05: Global Market Size (US$ Million) Analysis 2012 to 2022, By End User

Table 06: Global Market Size (US$ Million) Forecast 2023 to 2033, By End User

Table 07: Global Market Size (US$ Million) Analysis 2012 to 2022, By Region

Table 08: Global Market Size (US$ Million) Forecast 2023 to 2033, By Region

Table 09: North America Market Size (US$ Million) Analysis 2012 to 2022, By Country

Table 10: North America Market Size (US$ Million) Forecast 2023 to 2033, By Country

Table 11: North America Market Size (US$ Million) Analysis 2012 to 2022, By Diagnosis

Table 12: North America Market Size (US$ Million) Forecast 2023 to 2033, By Diagnosis

Table 13: North America Market Size (US$ Million) Analysis 2012 to 2022, By Indication

Table 14: North America Market Size (US$ Million) Forecast 2023 to 2033, By Indication

Table 15: North America Market Size (US$ Million) Analysis 2012 to 2022, By End User

Table 16: North America Market Size (US$ Million) Forecast 2023 to 2033, By End User

Table 17: Latin America Market Size (US$ Million) Analysis 2012 to 2022, By Country

Table 18: Latin America Market Size (US$ Million) Forecast 2023 to 2033, By Country

Table 19: Latin America Market Size (US$ Million) Analysis 2012 to 2022, By Diagnosis

Table 20: Latin America Market Size (US$ Million) Forecast 2023 to 2033, By Diagnosis

Table 21: Latin America Market Size (US$ Million) Analysis 2012 to 2022, By Indication

Table 22: Latin America Market Size (US$ Million) Forecast 2023 to 2033, By Indication

Table 23: Latin America Market Size (US$ Million) Analysis 2012 to 2022, By End User

Table 24: Latin America Market Size (US$ Million) Forecast 2023 to 2033, By End User

Table 25: Europe Market Size (US$ Million) Analysis 2012 to 2022, By Country

Table 26: Europe Market Size (US$ Million) Forecast 2023 to 2033, By Country

Table 27: Europe Market Size (US$ Million) Analysis 2012 to 2022, By Diagnosis

Table 28: Europe Market Size (US$ Million) Forecast 2023 to 2033, By Diagnosis

Table 29: Europe Market Size (US$ Million) Analysis 2012 to 2022, By Indication

Table 30: Europe Market Size (US$ Million) Forecast 2023 to 2033, By Indication

Table 31: Europe Market Size (US$ Million) Analysis 2012 to 2022, By End User

Table 32: Europe Market Size (US$ Million) Forecast 2023 to 2033, By End User

Table 33: South Asia Market Size (US$ Million) Analysis 2012 to 2022, By Country

Table 34: South Asia Market Size (US$ Million) Forecast 2023 to 2033, By Country

Table 35: South Asia Market Size (US$ Million) Analysis 2012 to 2022, By Diagnosis

Table 36: South Asia Market Size (US$ Million) Forecast 2023 to 2033, By Diagnosis

Table 37: South Asia Market Size (US$ Million) Analysis 2012 to 2022, By Indication

Table 38: South Asia Market Size (US$ Million) Forecast 2023 to 2033, By Indication

Table 39: South Asia Market Size (US$ Million) Analysis 2012 to 2022, By End User

Table 40: South Asia Market Size (US$ Million) Forecast 2023 to 2033, By End User

Table 41: East Asia Market Size (US$ Million) Analysis 2012 to 2022, By Country

Table 42: East Asia Market Size (US$ Million) Forecast 2023 to 2033, By Country

Table 43: East Asia Market Size (US$ Million) Analysis 2012 to 2022, By Diagnosis

Table 44: East Asia Market Size (US$ Million) Forecast 2023 to 2033, By Diagnosis

Table 45: East Asia Market Size (US$ Million) Analysis 2012 to 2022, By Indication

Table 46: East Asia Market Size (US$ Million) Forecast 2023 to 2033, By Indication

Table 47: East Asia Market Size (US$ Million) Analysis 2012 to 2022, By End User

Table 48: East Asia Market Size (US$ Million) Forecast 2023 to 2033, By End User

Table 49: Oceania Market Size (US$ Million) Analysis 2012 to 2022, By Country

Table 50: Oceania Market Size (US$ Million) Forecast 2023 to 2033, By Country

Table 51: Oceania Market Size (US$ Million) Analysis 2012 to 2022, By Diagnosis

Table 52: Oceania Market Size (US$ Million) Forecast 2023 to 2033, By Diagnosis

Table 53: Oceania Market Size (US$ Million) Analysis 2012 to 2022, By Indication

Table 54: Oceania Market Size (US$ Million) Forecast 2023 to 2033, By Indication

Table 55: Oceania Market Size (US$ Million) Analysis 2012 to 2022, By End User

Table 56: Oceania Market Size (US$ Million) Forecast 2023 to 2033, By End User

Table 57: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022, By Country

Table 58: Middle East & Africa Market Size (US$ Million) Forecast 2023 to 2033, By Country

Table 59: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022, By Diagnosis

Table 60: Middle East & Africa Market Size (US$ Million) Forecast 2023 to 2033, By Diagnosis

Table 61: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022, By Indication

Table 62: Middle East & Africa Market Size (US$ Million) Forecast 2023 to 2033, By Indication

Table 63: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022, By End User

Table 64: Middle East & Africa Market Size (US$ Million) Forecast 2023 to 2033, By End User

List of Charts

Figure 01: Global Market Split By Region, 2023 (E)

Figure 02: Global Market Split By Diagnosis, 2023 (E)

Figure 03: Global Market Split By Indication, 2023 (E)

Figure 04: Global Market Split By End User, 2023 (E)

Figure 05: Global Neurology Services Market Overview

Figure 06: Global Market - COVID-19 Impact, 2017 to 2033

Figure 07: Global Market Size (US$ Million) Analysis, 2012 to 2022

Figure 08: Global Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033

Figure 09: Global Market Absolute $ Opportunity Analysis, 2022 to 2033

Figure 10: Global Market Analysis By Diagnosis –2023 & 2033

Figure 11: Global Market Y-o-Y Growth Projections By Diagnosis, 2023 to 2033

Figure 12: Global Market Attractiveness, By Diagnosis, 2023- 2033

Figure 13: Global Market Analysis By Indication –2023 & 2033

Figure 14: Global Market Y-o-Y Growth Projections By Indication, 2023 to 2033

Figure 15: Global Market Attractiveness, By Indication, 2023- 2033

Figure 16: Global Market Analysis By End User –2023 & 2033

Figure 17: Global Market Y-o-Y Growth Projections By Indication, 2023 to 2033

Figure 18: Global Market Attractiveness, By End User, 2023- 2033

Figure 19: Global Market Analysis by Region–2023 & 2033

Figure 20: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033

Figure 21: Global Market Attractiveness, By Region, 2023 to 2033

Figure 22: North America Market Value Share, by Diagnosis, 2023 (E)

Figure 23: North America Market Value Share, by Indication, 2023 (E)

Figure 24: North America Market Value Share, by End User, 2023 (E)

Figure 25: North America Market Value Share, by Country, 2023 (E)

Figure 26: North America Market Size (US$ Million) Analysis, 2012 to 2022

Figure 27: North America Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033

Figure 28: North America Market Attractiveness Analysis, by Country

Figure 29: North America Market Attractiveness Analysis, By Diagnosis

Figure 30: North America Market Attractiveness Analysis, by Indication

Figure 31: North America Market Attractiveness Analysis, By End User

Figure 32: USA Market Value Proportion Analysis, 2022

Figure 33: Global Vs. USA Growth Comparison, 2022 to 2033

Figure 34: USA Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 35: USA Market Share Analysis (%), By Indication, 2022 & 2033

Figure 36: USA Market Share Analysis (%), By End User, 2022 & 2033

Figure 37: Canada Market Value Proportion Analysis, 2022

Figure 38: Global Vs. Canada Growth Comparison, 2022 to 2033

Figure 39: Canada Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 40: Canada Market Share Analysis (%), By Indication, 2022 & 2033

Figure 41: Canada Market Share Analysis (%), By End User, 2022 & 2033

Figure 42: Latin America Market Value Share, by Diagnosis, 2023 (E)

Figure 43: Latin America Market Value Share, by Indication, 2023 (E)

Figure 44: Latin America Market Value Share, by End User, 2023 (E)

Figure 45: Latin America Market Value Share, by Country, 2023 (E)

Figure 46: Latin America Market Size (US$ Million) Analysis, 2012 to 2022

Figure 47: Latin America Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033

Figure 48: Latin America Market Attractiveness Analysis, by Country

Figure 49: Latin America Market Attractiveness Analysis, By Diagnosis

Figure 50: Latin America Market Attractiveness Analysis, by Indication

Figure 51: Latin America Market Attractiveness Analysis, By End User

Figure 52: Brazil Market Value Proportion Analysis, 2022

Figure 53: Global Vs. Brazil Growth Comparison, 2022 to 2033

Figure 54: Brazil Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 55: Brazil Market Share Analysis (%), By Indication, 2022 & 2033

Figure 56: Brazil Market Share Analysis (%), By End User, 2022 & 2033

Figure 57: Mexico Market Value Proportion Analysis, 2022

Figure 58: Global Vs. Mexico Growth Comparison, 2022 to 2033

Figure 59: Mexico Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 60: Mexico Market Share Analysis (%), By Indication, 2022 & 2033

Figure 61: Mexico Market Share Analysis (%), By End User, 2022 & 2033

Figure 62: Argentina Market Value Proportion Analysis, 2022

Figure 63: Global Vs. Argentina Growth Comparison, 2022 to 2033

Figure 64: Argentina Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 65: Argentina Market Share Analysis (%), By Indication, 2022 & 2033

Figure 66: Argentina Market Share Analysis (%), By End User, 2022 & 2033

Figure 67: Europe Market Value Share, by Diagnosis, 2023 (E)

Figure 68: Europe Market Value Share, by Indication, 2023 (E)

Figure 69: Europe Market Value Share, by End User, 2023 (E)

Figure 70: Europe Market Value Share, by Country, 2023 (E)

Figure 71: Europe Market Size (US$ Million) Analysis, 2012 to 2022

Figure 72: Europe Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033

Figure 73: Europe Market Attractiveness Analysis, by Country

Figure 74: Europe Market Attractiveness Analysis, By Diagnosis

Figure 75: Europe Market Attractiveness Analysis, by Indication

Figure 76: Europe Market Attractiveness Analysis, By End User

Figure 77: Germany Market Value Proportion Analysis, 2022

Figure 78: Global Vs. Germany Growth Comparison, 2022 to 2033

Figure 79: Germany Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 80: Germany Market Share Analysis (%), By Indication, 2022 & 2033

Figure 81: Germany Market Share Analysis (%), By End User, 2022 & 2033

Figure 82: Italy Market Value Proportion Analysis, 2022

Figure 83: Global Vs. Italy Growth Comparison, 2022 to 2033

Figure 84: Italy Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 85: Italy Market Share Analysis (%), By Indication, 2022 & 2033

Figure 86: Italy Market Share Analysis (%), By End User, 2022 & 2033

Figure 87: France Market Value Proportion Analysis, 2022

Figure 88: Global Vs. France Growth Comparison, 2022 to 2033

Figure 89: France Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 90: France Market Share Analysis (%), By Indication, 2022 & 2033

Figure 91: France Market Share Analysis (%), By End User, 2022 & 2033

Figure 92: United kingdom Market Value Proportion Analysis, 2022

Figure 93: Global Vs. United kingdom Growth Comparison, 2022 to 2033

Figure 94: United kingdom Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 95: United kingdom Market Share Analysis (%), By Indication, 2022 & 2033

Figure 96: United kingdom Market Share Analysis (%), By End User, 2022 & 2033

Figure 97: Spain Market Value Proportion Analysis, 2022

Figure 98: Global Vs. Spain Growth Comparison, 2022 to 2033

Figure 99: Spain Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 100: Spain Market Share Analysis (%), By Indication, 2022 & 2033

Figure 101: Spain Market Share Analysis (%), By End User, 2022 & 2033

Figure 102: BENELUX Market Value Proportion Analysis, 2022

Figure 103: Global Vs. BENELUX Growth Comparison, 2022 to 2033

Figure 104: BENELUX Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 105: BENELUX Market Share Analysis (%), By Indication, 2022 & 2033

Figure 106: BENELUX Market Share Analysis (%), By End User, 2022 & 2033

Figure 107: Nordic Countries Market Value Proportion Analysis, 2022

Figure 108: Global Vs. Nordic Countries Growth Comparison, 2022 to 2033

Figure 109: Nordic Countries Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 110: Nordic Countries Market Share Analysis (%), By Indication, 2022 & 2033

Figure 111: Nordic Countries Market Share Analysis (%), By End User, 2022 & 2033

Figure 112: Russia Market Value Proportion Analysis, 2022

Figure 113: Global Vs. Russia Growth Comparison, 2022 to 2033

Figure 114: Russia Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 115: Russia Market Share Analysis (%), By Indication, 2022 & 2033

Figure 116: Russia Market Share Analysis (%), By End User, 2022 & 2033

Figure 117: South Asia Market Value Share, by Diagnosis, 2023 (E)

Figure 118: South Asia Market Value Share, by Indication, 2023 (E)

Figure 119: South Asia Market Value Share, by End User, 2023 (E)

Figure 120: South Asia Market Value Share, by Country, 2023 (E)

Figure 121: South Asia Market Size (US$ Million) Analysis, 2012 to 2022

Figure 122: South Asia Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033

Figure 123: South Asia Market Attractiveness Analysis, by Country

Figure 124: South Asia Market Attractiveness Analysis, By Diagnosis

Figure 125: South Asia Market Attractiveness Analysis, by Indication

Figure 126: South Asia Market Attractiveness Analysis, By End User

Figure 127: India Market Value Proportion Analysis, 2022

Figure 128: Global Vs. India Growth Comparison, 2022 to 2033

Figure 129: India Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 130: India Market Share Analysis (%), By Indication, 2022 & 2033

Figure 131: India Market Share Analysis (%), By End User, 2022 & 2033

Figure 132: Thailand Market Value Proportion Analysis, 2022

Figure 133: Global Vs. Thailand Growth Comparison, 2022 to 2033

Figure 134: Thailand Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 135: Thailand Market Share Analysis (%), By Indication, 2022 & 2033

Figure 136: Thailand Market Share Analysis (%), By End User, 2022 & 2033

Figure 137: Malaysia Market Value Proportion Analysis, 2022

Figure 138: Global Vs. Malaysia Growth Comparison, 2022 to 2033

Figure 139: Malaysia Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 140: Malaysia Market Share Analysis (%), By Indication, 2022 & 2033

Figure 141: Malaysia Market Share Analysis (%), By End User, 2022 & 2033

Figure 142: Philippines Market Value Proportion Analysis, 2022

Figure 143: Global Vs. Philippines Growth Comparison, 2022 to 2033

Figure 144: Philippines Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 145: Philippines Market Share Analysis (%), By Indication, 2022 & 2033

Figure 146: Philippines Market Share Analysis (%), By End User, 2022 & 2033

Figure 147: Indonesia Market Value Proportion Analysis, 2022

Figure 148: Global Vs. Indonesia Growth Comparison, 2022 to 2033

Figure 149: Indonesia Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 150: Indonesia Market Share Analysis (%), By Indication, 2022 & 2033

Figure 151: Indonesia Market Share Analysis (%), By End User, 2022 & 2033

Figure 152: Vietnam Market Value Proportion Analysis, 2022

Figure 153: Global Vs. Vietnam Growth Comparison, 2022 to 2033

Figure 154: Vietnam Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 155: Vietnam Market Share Analysis (%), By Indication, 2022 & 2033

Figure 156: Vietnam Market Share Analysis (%), By End User, 2022 & 2033

Figure 157: East Asia Market Value Share, by Diagnosis, 2023 (E)

Figure 158: East Asia Market Value Share, by Indication, 2023 (E)

Figure 159: East Asia Market Value Share, by End User, 2023 (E)

Figure 160: East Asia Market Value Share, by Country, 2023 (E)

Figure 161: East Asia Market Size (US$ Million) Analysis, 2012 to 2022

Figure 162: East Asia Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033

Figure 163: East Asia Market Attractiveness Analysis, by Country

Figure 164: East Asia Market Attractiveness Analysis, By Diagnosis

Figure 165: East Asia Market Attractiveness Analysis, by Indication

Figure 166: East Asia Market Attractiveness Analysis, By End User

Figure 167: China Market Value Proportion Analysis, 2022

Figure 168: Global Vs. China Growth Comparison, 2022 to 2033

Figure 169: China Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 170: China Market Share Analysis (%), By Indication, 2022 & 2033

Figure 171: China Market Share Analysis (%), By End User, 2022 & 2033

Figure 172: Japan Market Value Proportion Analysis, 2022

Figure 173: Global Vs. Japan Growth Comparison, 2022 to 2033

Figure 174: Japan Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 175: Japan Market Share Analysis (%), By Indication, 2022 & 2033

Figure 176: Japan Market Share Analysis (%), By End User, 2022 & 2033

Figure 177: South Korea Market Value Proportion Analysis, 2022

Figure 178: Global Vs. South Korea Growth Comparison, 2022 to 2033

Figure 179: South Korea Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 180: South Korea Market Share Analysis (%), By Indication, 2022 & 2033

Figure 181: South Korea Market Share Analysis (%), By End User, 2022 & 2033

Figure 182: Oceania Market Value Share, by Diagnosis, 2023 (E)

Figure 183: Oceania Market Value Share, by Indication, 2023 (E)

Figure 184: Oceania Market Value Share, by End User, 2023 (E)

Figure 185: Oceania Market Value Share, by Country, 2023 (E)

Figure 186: Oceania Market Size (US$ Million) Analysis, 2012 to 2022

Figure 187: Oceania Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033

Figure 188: Oceania Market Attractiveness Analysis, by Country

Figure 189: Oceania Market Attractiveness Analysis, By Diagnosis

Figure 190: Oceania Market Attractiveness Analysis, by Indication

Figure 191: Oceania Market Attractiveness Analysis, By End User

Figure 192: Australia Market Value Proportion Analysis, 2022

Figure 193: Global Vs. Australia Growth Comparison, 2022 to 2033

Figure 194: Australia Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 195: Australia Market Share Analysis (%), By Indication, 2022 & 2033

Figure 196: Australia Market Share Analysis (%), By End User, 2022 & 2033

Figure 197: New Zealand Market Value Proportion Analysis, 2022

Figure 198: Global Vs. New Zealand Growth Comparison, 2022 to 2033

Figure 199: New Zealand Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 200: New Zealand Market Share Analysis (%), By Indication, 2022 & 2033

Figure 201: New Zealand Market Share Analysis (%), By End User, 2022 & 2033

Figure 202: Middle East & Africa Market Value Share, by Diagnosis, 2023 (E)

Figure 203: Middle East & Africa Market Value Share, by Indication, 2023 (E)

Figure 204: Middle East & Africa Market Value Share, by End User, 2023 (E)

Figure 205: Middle East & Africa Market Value Share, by Country, 2023 (E)

Figure 206: Middle East & Africa Market Size (US$ Million) Analysis, 2012 to 2022

Figure 207: Middle East & Africa Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033

Figure 208: Middle East & Africa Market Attractiveness Analysis, by Country

Figure 209: Middle East & Africa Market Attractiveness Analysis, By Diagnosis

Figure 210: Middle East & Africa Market Attractiveness Analysis, by Indication

Figure 211: Middle East & Africa Market Attractiveness Analysis, By End User

Figure 212: GCC Countries Market Value Proportion Analysis, 2022

Figure 213: Global Vs. GCC Countries Growth Comparison, 2022 to 2033

Figure 214: GCC Countries Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 215: GCC Countries Market Share Analysis (%), By Indication, 2022 & 2033

Figure 216: GCC Countries Market Share Analysis (%), By End User, 2022 & 2033

Figure 217: Israel Market Value Proportion Analysis, 2022

Figure 218: Global Vs. Israel Growth Comparison, 2022 to 2033

Figure 219: Israel Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 220: Israel Market Share Analysis (%), By Indication, 2022 & 2033

Figure 221: Israel Market Share Analysis (%), By End User, 2022 & 2033

Figure 222: Türkiye Market Value Proportion Analysis, 2022

Figure 223: Global Vs. Türkiye Growth Comparison, 2022 to 2033

Figure 224: Türkiye Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 225: Türkiye Market Share Analysis (%), By Indication, 2022 & 2033

Figure 226: Türkiye Market Share Analysis (%), By End User, 2022 & 2033

Figure 227: South Africa Market Value Proportion Analysis, 2022

Figure 228: Global Vs. South Africa Growth Comparison, 2022 to 2033

Figure 229: South Africa Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 230: South Africa Market Share Analysis (%), By Indication, 2022 & 2033

Figure 231: South Africa Market Share Analysis (%), By End User, 2022 & 2033

Figure 232: North Africa Market Value Proportion Analysis, 2022

Figure 233: Global Vs. North Africa Growth Comparison, 2022 to 2033

Figure 234: North Africa Market Share Analysis (%), By Diagnosis, 2022 & 2033

Figure 235: North Africa Market Share Analysis (%), By Indication, 2022 & 2033

Figure 236: North Africa Market Share Analysis (%), By End User, 2022 & 2033

Recommendations

Healthcare

Brain Imaging And Neuroimaging Market

Published : July 2023

Healthcare

Brain Tumor Treatment Market

Published : July 2023

Healthcare

Brain Monitoring Systems Market

Published : January 2023

Explore Healthcare Insights

View Reports

Cognitive Diagnostics Market